目的 探討甲硝唑聯(lián)合唯陰康治療細(xì)菌性陰道?。˙V）的臨床療效。方法 將150例BV患者隨機(jī)分為兩組，單純口服甲硝唑組（對(duì)照組）75例，甲硝唑聯(lián)合唯陰康用藥組（治療組）75例，用藥7 d,觀察治療后兩組的有效率及復(fù)發(fā)率。結(jié)果 兩組患者停藥后第7天的有效率比較無統(tǒng)計(jì)學(xué)差異，停藥后第30天有效率治療組明顯高于對(duì)照組（P＜0.05），治療組復(fù)發(fā)率明顯低于對(duì)照組（P＜0.05）。結(jié)論 甲硝唑聯(lián)合唯陰康治療BV療效好，優(yōu)于單純甲硝唑?qū)φ战M，復(fù)發(fā)率低，且未見不良反應(yīng)，值得臨床推廣。

Objective To explore the clinical efficacy of co-using Metronidazole and Weiyinkang in treatment of bacterial vaginitis (BV). Methods Cases 150 diagnosed as BV definitely were divided into control group (treated with Metronidazole) (n=75) and treatment group (treated with Metronidazole and Weiyinkang) (n=75), they used for 7 days then the effective rates and relapse rates of the two groups were observed after treatment. Results There was no significant difference in effective rate between the two groups after withdrawal of day 7, but the effective rate of treatment group was significantly higher than that of control group (P＜0.05) after withdrawal of day 30; the relapse rate of treatment group was significantly lower than that of control group (P＜0.05). Conclusion Metronidazole and Weiyinkang are effective in treatment of BV with low relapse rate and no adverse reaction, which is worth of spreading in clinic.